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Abstract In a previous paper we showed that the nitric oxide
(NO) donors azide and hydroxylamine inhibited eosinophil
apoptosis. Azide and hydroxylamine generate a nitrosyl-heme
complex ^ due to endogenous catalase activity ^ which activates
soluble guanylate cyclase. In contrast, in the present paper, we
show that NO donors (SNAP, SIN-1, S-nitroso-L-cysteine,
NOC-18) which spontaneously release NO in physiological
solutions did not support the survival of eosinophils and induced
apoptosis or necrosis. However, the addition of hematin (the
ferric form of heme) together with low doses of NO (SNAP
10 WM) promoted eosinophil survival. In conclusion, we propose
that NO and heme (e.g. from heme-containing enzymes such as
peroxidase or catalase), both released in inflammation sites,
could form nitrosyl-heme and thus promote eosinophilic inflam-
mation.
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1. Introduction
Eosinophils accumulate at the sites of allergic in£ammation
and further enhance in£ammation through the release of lipid
mediators, cationic proteins and cytokines [1]. Although the
eosinophils are short-lived cells, they can survive in tissues for
several days. Some cytokines ^ such as granulocyte/macro-
phage colony stimulating factor (GM-CSF), interleukin (IL)-
3 or IL-5 ^ which are released at the sites of in£ammation
promote eosinophil survival in vitro [2]. In their absence, eo-
sinophils spontaneously undergo a program of cell death with
the biochemical and morphological features of apoptosis [3,4].
In a previous paper, we pointed out the role of soluble
guanylate cyclase (sGC) and its product cGMP in the inhibi-
tion of the spontaneous apoptosis of cytokine-deprived eosin-
ophils [3]. sGC is a heme-containing enzyme and its activation
can be achieved by the binding of nitric oxide (NO) to heme.
Activation of sGC can also be obtained by compounds such
as azide or hydroxylamine. The sGC activation by these
compounds requires an enzymatic step which is catalyzed by
the heme-containing enzyme catalase in the presence of H2O2
[4,5]. A nitrosyl-heme complex is formed which competes with
the free heme of sGC and thus activates the formation of
cGMP [6].
In the present paper we studied the e¡ect of pharmacolog-
ical compounds which spontaneously release NO in the exter-
nal medium without enzyme requirement. We show that ^ in
contrast with enzymatically formed NO ^ free NO induces
eosinophil death by apoptosis or necrosis. Finally, we propose
that NO is able to promote eosinophil survival when pre-
sented to the sGC in the nitrosyl-heme form.
2. Materials and methods
2.1. Reagents
SIN-1 (3-morpholino-sydnonimine) and SIN-1C (synthesized by
Cassela AG, Frankfurt, Germany, graciously provided by Dr. Wi-
nicki, Hoechst, France), S-nitroso-N-acetyl-penicillamine (SNAP:
Biomol, Tebu, Paris, France), recombinant human IL-5 and GM-
CSF (Genzyme, Cambridge, MA, USA), sodium azide (Merck, Darm-
stadt, Germany), hydroxylamine hydrochloride, hematin (Sigma, St.
Louis, MO, USA), were obtained as mentioned. S-Nitrosocysteine
was prepared as described [7]. Brie£y, 100 mM of L-cysteine (Gibco
BRL, Gaithersburg, MD, USA) and 100 mM of NaNO2 were added
in 0.5 N HCl for 30 min at room temperature. The solution was
neutralized with NaOH just before use and diluted in RPMI medium.
The synthesis of S-nitroso-L-cysteine was con¢rmed by the method of
Saville [8]. The NO donors were assayed for release of free NO in
culture conditions (RPMI medium, see above) using an NO meter
(Iso-NO, World Precision Instrument, Aston, Stevenage, Hertford-
shire, UK). As expected, SNAP and SIN-1 released NO for hours,
whereas S-nitroso-L-cysteine released NO in a few minutes. NOC-18
(ICN Pharmaceuticals France, Orsay, France), which releases NO for
periods of s 18 h, was also used.
2.2. Human blood eosinophil preparation
Venous blood from healthy subjects was sedimented in the presence
of dextran. The cell-rich supernatant was layered onto a cushion of
Ficoll (density 1.077). The cell pellet containing eosinophils and neu-
trophils was harvested after hypotonic lysis of red cells. An immuno-
magnetic cell separation system (MACS system; Miltenyi Biotec) was
used to purify the eosinophils by negative separation with anti-CD16
magnetic microbeads. After passage through the column for magnetic
separation, the purity of the cell suspension (above 95%) was assessed
after speci¢c staining of the eosinophils.
2.3. Cultures of eosinophils
Freshly isolated eosinophils (2^4U105 cells/ml) were suspended in
RPMI 1640 supplemented with 0.1 mM non-essential amino acids,
100 U/ml penicillin, 100 Wg/ml streptomycin, 10 mM HEPES, 2 mM
L-glutamine and 10% (v/v) fetal calf serum. Aliquots of 180 Wl were
placed into 96-well £at-bottomed microtiter plates (Costar, Cam-
bridge, MA, USA). 20 Wl of IL-5, nitric oxide donors (SNAP, SIN-
1, S-nitroso-L-cysteine, NOC-18) or hematin at de¢ned concentrations
or diluting medium alone were added. The plates were maintained at
37‡C in a 5% CO2 atmosphere for 48 h.
2.4. Eosinophil viability and apoptosis
2.4.1. Trypan blue exclusion. The viability of eosinophils was as-
sessed by trypan blue exclusion. The percentages of viable cells were
calculated over the number of viable cells present at the beginning of
the culture (i.e. around 100% of viable cells).
2.4.2. Apoptosis of eosinophils
2.4.2.1. Eosinophil cytology. Cytocentrifuge slides were stained as
described above in Section 2.2 and were examined under a light mi-
croscope (U400) using oil immersion. The proportion of intact eosin-
ophils was assessed as previously described [9]. Typically, apoptotic
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eosinophils show nuclear pycnosis and cytoplasmic condensation. At
a further state, the limit between the nucleus and the cytoplasm van-
ishes and the nucleus structures disappear. Moreover, the cell size
decrease is particularly marked. The eosinophils appear then as ‘gran-
ule bags’. At least 200 cells were examined for each slide.
2.4.2.2. Acridine orange method. In some experiments, the acridine
orange method was used as an alternative method to show apoptosis.
An aliquot of cell suspension was added to an equal volume of acri-
dine orange (Sigma) at 10 Wg/ml in phosphate-bu¡ered saline and
observed in £uorescence microscopy. Apoptotic eosinophils appeared
with a bright condensed pycnotic nucleus and at a further step nucleus
structures disappeared. At least 200 cells were examined for each
experimental point.
2.4.2.3. In situ DNA fragmentation. The presence of fragmented
DNA was evidenced in situ using the TUNEL method. This method
was used according to the manufacturer’s instructions (Apoptosis De-
tection System, Promega). Brie£y, the eosinophils of each well were
cytocentrifuged and ¢xed in a formaldehyde solution at 4% (25 min;
4‡C). After washing, the preparations were permeabilized in a 2%
Triton X-100 solution (5 min; 20‡C). The cells were then incubated
(1 h; 37‡C) in the presence of a solution containing £uorescein-12-
dUTP and terminal deoxynucleotidyl transferase. The samples were
examined under a £uorescence microscope using a £uorescein ¢lter
set.
2.5. Statistical analysis
Statistical analysis was performed using Student’s t-test for paired
variates. Di¡erences were considered to be statistically signi¢cant
when P6 0.05.
3. Results
3.1. NO released in the external medium in large amounts
inhibits apoptosis but does not support the survival of
cytokine-deprived human eosinophils
Freshly isolated human eosinophils were incubated in the
presence of three di¡erent NO donors: SIN-1 and SNAP,
which release NO in a sustained manner, and S-nitroso-L-cys-
teine which releases NO in a short time. Monitoring the apop-
tosis of the eosinophils with the acridine orange method in-
dicated that apoptosis at 48 h was strongly inhibited by SNAP
and SIN-1. The appearance of the nuclear events of apoptosis
was strongly decreased in the presence of SIN-1 (1^5 mM)
and SNAP (1^5 mM) in a dose-responsive manner (Fig. 1).
Thus, in the presence of 5 mM SNAP, 12 þ 3% (P6 0.01;
n = 5) of the eosinophils present in the 48-h culture were apop-
totic and 25 þ 4% (P6 0.001; n = 5) in the presence of 5 mM
SIN-1 vs. 89 þ 3% in the presence of the diluting medium
alone (Fig. 1). The brief NO release from S-nitroso-L-cysteine
was enough to inhibit apoptosis (Fig. 1). However, in sharp
contrast with apoptosis inhibition, SNAP and SIN-1 did not
increase the eosinophil survival as expected. Indeed, after 48
h, only 34 þ 4% (P6 0.05; n = 11) of the eosinophils present at
the beginning of the culture excluded trypan blue in the pres-
ence of 3 mM SIN-1 vs. 21 þ 2% in the presence of the dilut-
ing medium alone (Fig. 1). In the presence of SNAP, the
eosinophil viability was not signi¢cantly increased. As nega-
tive controls, SIN-1C, the inactive metabolite of SIN-1,
NaNO2, and degraded SNAP were without e¡ect on both
eosinophil survival and apoptosis (data not shown).
These deleterious e¡ects on survival were con¢rmed by mi-
croscopic observations which indicated that these NO donors
profoundly modi¢ed cell morphology.
(1) Prolongation of the culture of the eosinophils of the
SIN-1- or SNAP-treated eosinophils at NO concentrations
which blocked the apoptosis process ¢nally led to cell lysis
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Fig. 1. E¡ect of NO donors on apoptosis and survival of cytokine-
deprived eosinophils. Eosinophils were incubated in the presence of
S-nitroso-L-cysteine (SNOC), SNAP, SIN-1 at de¢ned concentra-
tions, or diluting bu¡er alone as control. After 48 h, the percentages
of viable eosinophils and the percentages of apoptotic cells were as-
sessed (n = 3^11 independent experiments). *P6 0.05, **P6 0.01,
***P6 0.001 as compared to control values.
Fig. 2. E¡ect of brief pulses or low sustained release of NO on sur-
vival and apoptosis of IL-5-primed eosinophil. A and B: Human
eosinophils were cultured in the presence of IL-5 (10 pM) and S-ni-
troso-L-cysteine at de¢ned concentration was added at t = 0 (open
circles), at t = 0 and 18 h (open triangles), at t = 0, 18 h, and 26 h
(closed squares). The percentages of viable cells (A) and apoptotic
cells (B) were assessed at 48 h (one experiment representative of
three). C and D: Eosinophils were cultured in the presence of IL-5
(10 pM) and NOC-18 at de¢ned concentrations. After 24 and 48 h
of culture, the percentages of viable cells (C) and apoptotic cells (D)
were assessed (one experiment representative of three).
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(necrosis) without the apoptosis step. This was in contrast
with other inhibitors of eosinophil apoptosis (e.g. IL-5 or
azide) which delay apoptosis without a necrosis process
(data not shown).
(2) Under phase-contrast microscopy, SIN-1- or SNAP-
treated eosinophils appeared with a large, normal volume
and looked like viable eosinophils. However, after cytocentri-
fugation on glass slides, the SIN-1- or SNAP-treated eosino-
phils became strongly shrunken with a condensed cytoplasm
around a bilobed non-apoptotic nucleus (data not shown).
Again, this was in sharp contrast with IL-5- or azide-treated
eosinophils which kept a normal aspect after cytocentrifuga-
tion.
3.2. Brief or low sustained release of external NO from
pharmacological NO donors induces the apoptosis
of IL-5-primed human eosinophils
We then studied the e¡ect of NO donors in the external
medium on IL-5-primed eosinophils. S-Nitroso-L-cysteine,
which was previously shown to be without e¡ect on cyto-
kine-deprived eosinophils, still induced apoptosis of IL-5-
primed eosinophils. Indeed, we observed that concentrations
of S-nitroso-L-cysteine as low as 100^300 WM induced the
apoptosis of eosinophils maintained in survival by IL-5, par-
ticularly when this treatment was repeated during the culture
period (Fig. 2A,B). Another NO donor, NOC-18, which re-
leases small amounts of NO for a long time, was also used
[10]. This compound also decreased the survival of eosinophils
and increased their apoptosis (Fig. 2C,D). The apoptosis in-
duced by S-nitroso-L-cysteine and NOC-18 was typical. Pyc-
notic nuclei (round, dense nuclei) due to chromatin conden-
sation and a decreased cell diameter were observed. However,
in the majority of apoptotic eosinophils, nuclear structures
were lost and eosinophils appeared as ‘granule bags’ of small
diameter. The DNA fragmentation was systematically evi-
denced in situ in the pycnotic nuclei (data not shown).
3.3. Low doses of NO in the presence of hematin increase the
survival of cytokine-deprived eosinophils
NO and heme react easily together to form a potent acti-
vator of sGC. We thus added hematin (the ferric form of
heme) and SNAP at low concentrations (3^10 WM). SNAP
or hematin (10 WM) alone did not signi¢cantly modify eosin-
ophil survival and apoptosis. However, when present together
the survival of eosinophils increased and their apoptosis
decreased (Fig. 3). Indeed, in the presence of 10 WM SNAP
and 10 WM hematin eosinophil survival after a 48-h incuba-
tion increased from 15 þ 2% to 45 þ 11% (P6 0.05; n = 3) and
apoptosis decreased from 68 þ 7% to 47 þ 14% (P6 0.05).
4. Discussion
In a previous paper, we observed that the pharmacological
activation of the sGC (by azide or hydroxylamine) and cGMP
^ the product of sGC ^ delayed eosinophil apoptosis [3]. This
suggested that the sGC-cGMP pathway played an important
role in eosinophil survival.
The activation of sGC by azide and hydroxylamine involves
the formation of NO through an enzymatic process. Indeed, it
has been shown that azide or hydroxylamine ^ in the presence
of catalase and H2O2 ^ form a nitrosyl-heme complex which
activates sGC [4,5].
In the present paper, we studied the e¡ect of NO sponta-
neously released in the external medium without the need for
an enzymatic step. The results show that a brief release of NO
(from S-nitroso-L-cysteine) did not modify the survival and
the spontaneous apoptosis of cytokine-deprived eosinophils.
In contrast, when NO was released at high rates from SIN-
1 at mM concentrations, the apoptosis was blocked but was
accompanied by toxic/necrotic processes. It should be noted
that SIN-1 is a donor of both NO and superoxide anion.
Thus, we cannot exclude that the e¡ects observed with SIN-
1 are due ^ at least in part ^ to peroxynitrite. However, sim-
ilar results were obtained with SNAP, a compound which also
releases NO for hours without the simultaneous release of
superoxide anion. With these high and sustained doses of
NO, the cell homeostasis was most probably highly altered.
Thus, the eosinophils could not undergo a programmed cell
death and consequently necrosis occurred.
Recently, it has been proposed that not only azide and
hydroxylamine but also SNAP ^ particularly at mM concen-
trations ^ inhibited the eosinophil apoptosis mediated by Fas
[11]. However, trypan blue tests were not reported, thus ques-
tioning the physiological relevance of these results. Indeed, the
present experiments clearly point out the necessity to carefully
check that eosinophil viability is conversely increased when
apoptosis is inhibited by NO donors.
When NO was released during brief pulses or at low levels
for long periods (from S-nitroso-L-cysteine or NOC-18, re-
spectively), it decreased the survival of IL-5-primed eosino-
phils through an apoptotic process. Thus, taken together the
present results and our previous article [3], there is a large
discrepancy between the two types of NO donors. Indeed,
enzymatically formed NO ^ which complexes with heme ^
supports eosinophil survival via the activation of the soluble
guanylate cyclase. In contrast, free NO released in the external
medium induced the death of IL-5-primed eosinophils. The
signals induced by NO which lead to eosinophil apoptosis
remain unknown and will require further investigations. One
can postulate that protein phosphorylations mediated by IL-5
in IL-5-primed eosinophils are possible targets for NO. Thus,
inhibition of IL-5 signaling in eosinophils will lead to apop-
tosis.
NO has a great a⁄nity for heme and spontaneously forms a
nitrosyl-heme complex both with the ferrous (heme) or the
ferric (hematin) forms of heme [12]. Moreover, both NO
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Fig. 3. E¡et of low doses of SNAP in the presence of hematin on
eosinophil survival and apoptosis. Eosinophils were cultured in the
presence of SNAP at de¢ned concentrations and hematin (10 WM).
After 48 h of culture, the percentages of viable cells (A) and apop-
totic cells (B) were assessed (n=3 independent experiments).
*P6 0.05 as compared to control values.
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and heme are present in in£ammatory sites. Indeed, large
amounts of heme-containing enzymes (catalase, peroxidases)
are released during the degranulation of in£ammatory cells
(neutrophils, eosinophils, etc.) or during necrosis of tissues.
Consequently, we postulated that NO which is produced dur-
ing in£ammation binds to heme and thus promotes eosinophil
survival. This was indeed the case in vitro since the addition
of low concentrations of a NO donor (SNAP 3^10 WM),
which was without e¡ect alone, signi¢cantly increased eosino-
phil survival in the presence of hematin (Fig. 3).
In conclusion, we show that free NO induces eosinophil
death in vitro. In contrast, we propose that NO could increase
eosinophil viability when it is presented to the sGC in the
nitrosyl-heme form. Moreover, nitrosyl-heme could be a
transport form of NO. Indeed, NO has a brief half-life and
NO-heme could represent a stable form of NO. The increase
of eosinophil survival by nitrosyl-heme could be a physiolog-
ically relevant mechanism at the sites of allergy and in£am-
mation.
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